Onesource Specialty Pharma Limited (ONESOURCE) Q2 FY27 Financial Results: PAT ₹637 Cr & Revenue ₹4,490 Cr
| Metric | Value |
|---|---|
| Revenue | ₹4,490 Cr |
| Net Profit (PAT) | ₹637 Cr |
OneSource Specialty Pharma reported Q1FY27 revenue of ₹4,490m, up 37% YoY and 5% QoQ, driven by semaglutide commercialization and new MSA contracts. EBITDA rose 39% YoY to ₹1,233m with margin expanding 600bps to 27.5%, reflecting operating leverage. Adjusted PAT increased 72% YoY to ₹637m, with adjusted EPS at [amount not verified]FY28 guidance reaffirmed $400m organic revenue and 40% EBITDA margin. The company highlighted capacity expansion, including a second cartridge line commercializing in Q2, and strengthened biosimilics and GLP-1 franchise momentum.
About Onesource Specialty Pharma Limited (ONESOURCE)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when ONESOURCE files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ONESOURCE — Free💡 Ask AI about this filing
📊 More ONESOURCE filings
- 🔴 Annual Report — 31 August 2026 OneSource Specialty Pharma Ltd (ONESOURCE) filed its Integrated Annual Report 2025-26 on BSE (August...
- 🟡 Sustainability Report — 31 August 2026 OneSource Specialty Pharma Limited submitted its Business Responsibility and Sustainability Report (...
- 🔴 Annual Report — 31 August 2026 OneSource Specialty Pharma Ltd (ONESOURCE) reported FY26 revenue of ₹14,216 million (down 2% YoY), E...
- 🔴 Announcement — 31 August 2026 OneSource Specialty Pharma announced an in-person analyst and institutional investor meeting on Sept...
- 🟡 Board Meeting — 31 August 2026 The 19th AGM of OneSource Specialty Pharma Ltd (ONESOURCE) is scheduled for September 23, 2026, via ...
🔥 Also filed on 24 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ONESOURCE files new disclosures
Track ONESOURCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ONESOURCE — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd